<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <italic class="italic">M. tuberculosis</italic> as an intracellular pathogen causes pandemic tuberculosis (TB) (
 <xref rid="B21" ref-type="bibr" class="xref">21</xref>) leading to the death of about 3 million people per year worldwide. Thus, it is necessary to treat TB through the use of novel drugs, especially in the case of multi-drug-resistant tuberculosis strain. MDR-TB is resistant to conventional drugs such as isoniazid and rifampicin (
 <xref rid="B22" ref-type="bibr" class="xref">22</xref>–
 <xref rid="B23" ref-type="bibr" class="xref">23</xref>). Anti-TB activity of 
 <italic class="italic">L. officinale</italic> oil is comparable to other results, for example the essential oil of laurel and anise had activity against 
 <italic class="italic">M. tuberclosis</italic> with MIC = 100 μg/ml (
 <xref rid="B3" ref-type="bibr" class="xref">3</xref>). Also the MICs related to three essential oils extracted from 
 <italic class="italic">Salvia aratocensis, Turnera diffusa</italic> and 
 <italic class="italic">Lippia Americana</italic> were equal to 125 μg/ml against 
 <italic class="italic">M. tuberclosis</italic> (
 <xref rid="B4" ref-type="bibr" class="xref">4</xref>).
</p>
